Tag Archives: chemotherapy

NWO: Spinoza Prize / Stevin Prize, the highest distinction in Dutch Science, awarded to six outstanding researchers

(PRESS RELEASE) THE HAGUE, 19-Jun-2020 — /EuropaWire/ — The Dutch Research Council (NWO) has announced that six researchers will receive the highest awards in science in the Netherlands. The Spinoza Prize, emphasised on the scientific work and fundamental questions, will … Read the full press release

University of Zurich researchers announce novel immunotherapy against leukaemia

The new immunotherapy will be tested in humans as soon as possible (PRESS RELEASE) ZURICH, 8-May-2020 — /EuropaWire/ — University of Zurich researchers have announced a study that is showing how hematopoietic stem cells from a healthy donor can help … Read the full press release

Research evaluated the effectiveness of three-month course chemotherapy for colorectal cancer versus the standard six-month treatment regimen

SOUTHAMPTON, 02-Apr-2018 — /EuropaWire/ — Many patients receiving chemotherapy following surgery for bowel cancer may only need three months treatment rather than the six months currently given, new research published in Lancet Oncology has shown. An international clinical trial, funded by … Read the full press release

Roche: Phase III IMpower131 study met its co-primary endpoint of progression-free survival of people with a type of advanced squamous lung cancer

BASEL, 20-Mar-2018 — /EuropaWire/ — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the Phase III IMpower131 study met its co-primary endpoint of progression-free survival (PFS) and demonstrated that the combination of TECENTRIQ (atezolizumab) plus chemotherapy (carboplatin and Abraxane [albumin-bound … Read the full press release

AstraZeneca: US FDA approval for Imfinzi for the treatment of patients with unresectable Stage III non-small cell lung cancer

Imfinzi is the only immunotherapy approved for patients with unresectable Stage III non-small cell lung cancer Imfinzi showed an 11.2 month improvement in median progression-free survival (16.8 months compared to 5.6 months on placebo) CAMBRIDGE, 22-Feb-2018 — /EuropaWire/ — AstraZeneca and … Read the full press release

University of Liverpool identifies the mechanism causing resistance of pancreatic cancer cells to chemotherapy

LIVERPOOL, 25-Nov-2016 — /EuropaWire/ — A pioneering University of Liverpool research team have published a study that identifies the mechanism in the human body that causes resistance of pancreatic cancer cells to chemotherapy. Pancreatic cancer is one of the leading … Read the full press release